Brief: Pyxis Oncology Names Thomas Civik as Interim CEO
03/02/2026 13:25
Feb 3 (Reuters) - Pyxis Oncology Inc PYXS.O: PYXIS ONCOLOGY ANNOUNCES INTERIM CEO APPOINTMENT AND LEADERSHIP TRANSITION TO SUPPORT STRATEGIC FOCUS AND PROGRAM CONTINUITY PYXIS ONCOLOGY INC - THOMAS CIVIK APPOINTED INTERIM CEO OF PYXIS ONCOLOGY PYXIS ONCOLOGY INC - LARA S. SULLIVAN STEPS DOWN AS PRESIDENT, CEO, AND CMO Source text: ID:nGNX24frky Further company coverage: PYXS.O ((Reuters.Briefs@thomsonreuters.com;))